Pancreatic Cancer Research

ResearcherDalian Medical UniversityNo recent work listed

Haifeng Luo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3519-7408; OpenAlex author ID A5103254998. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper

Papers 7

  1. Correlation between Macrophage Polarization and PD-L1-Related Tumor Microenvironmental Alteration and Metastasis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2023/7971306↗
  2. Cancer associated fibroblasts (CAFs) derived exosomes with A promoted liver metastasis of pancreatic cancer by regulating C through transcription factor B Co-author DOI 10.21203/rs.3.rs-1464033/v1↗
  3. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go? Last author DOI 10.3389/fonc.2022.828223↗
  4. Safety and efficacy of S1 monotherapy or combined with nab-paclitaxel in advanced elderly pancreatic cancer patients: A meta-analysis. Last author DOI 10.1097/md.0000000000026342↗
  5. Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long-Term Survival in Pancreatic Cancer. Co-author DOI 10.1155/2020/1570862↗
  6. Ubiquitin‑specific protease 22‑induced autophagy is correlated with poor prognosis of pancreatic cancer. Co-author DOI 10.3892/or.2014.3508↗
  7. The therapeutic effect of cytokine-induced killer cells on pancreatic cancer enhanced by dendritic cells pulsed with K-ras mutant peptide. Co-author DOI 10.1155/2011/649359↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guang Tan · 5 shared papers, 2011–2023 · strength 0.61
  2. Jiangning Gu · 4 shared papers, 2020–2023 · strength 0.51
  3. Dan Chen · 3 shared papers, 2021–2023 · strength 0.41
  4. Chenqi Wang · 3 shared papers, 2021–2023 · strength 0.41
  5. Jian Du · 3 shared papers, 2020–2022 · strength 0.40
  6. Yunlong Chen · 2 shared papers, 2021–2022 · strength 0.25
  7. Xiang 'Anthony' Chen · 2 shared papers, 2021–2022 · strength 0.25
  8. Zhen Ning · 2 shared papers, 2014–2022 · strength 0.23
  9. Lili Yang · 1 shared paper, 2022 · strength 0.13
  10. Gang Wei · 1 shared paper, 2020 · strength 0.10
  11. Di Wang · 1 shared paper, 2020 · strength 0.10
  12. Zhiqiang Zhang · 1 shared paper, 2020 · strength 0.10
  13. Jinxiao Liang · 1 shared paper, 2014 · strength 0.04
  14. Zhongyu Wang · 1 shared paper, 2014 · strength 0.04
  15. Aman Wang · 1 shared paper, 2014 · strength 0.04
  16. Zhongyu Wang · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.